News
CATTI and Cell and Gene Therapy Catapult partner to establish international best practice standards in advanced therapies manufacturing training
October 12, 2023 (London, United Kingdoms), (Montreal, Canada) — The Canadian Advanced Therapies Training Institute (CATTI) and Cell and Gene Therapy Catapult (CGT Catapult) have entered into an agreement to advance regenerative medicine, including cell and gene therapy training locally and globally. Both institutions have agreed to the development of joint activities to address issues of mutual interest. The ultimate goal is to establish international best practice standards in advanced therapies manufacturing training.
CATTI opens a cell and gene therapy training centre of excellence at the University of Guelph
GUELPH, ON, May 15, 2023 /CNW/ – The Canadian Advanced Therapies Training Institute (CATTI) Inc. has launched its first in-person training site at the University of Guelph through a partnership with OmniaBio Inc., CCRM and the university. The training program, to begin in summer 2023, will cater to recent post-secondary graduates, industry professionals and companies growing their roster of clean room manufacturing staff. The fast growth of cell and gene therapies (CGTs) has made it a challenge for the global industry to keep up with talent requirements. This new CGT technical training site will begin to address the industry’s critical training needs and represents the first stage of a larger, multi-site training strategy for CATTI. Read full press release.